Spray Venture Partners

Spray Venture Partners is a venture capital firm specializing in early-stage investments within the healthcare and life sciences sectors. The firm focuses on identifying and supporting emerging healthcare technology companies. It emphasizes a hands-on approach, collaborating closely with clinical and technical founders to foster innovation. The firm's core capability lies in helping portfolio companies develop, market, and deploy novel technologies designed to address significant unmet needs in global health.

The firm was founded in 1996 by Kevin Connors and Dan Cole, who served as General Partners. Kevin Connors, an accomplished entrepreneur and seasoned venture investor, brought significant pedigree to the firm, having co-founded several healthcare technology companies and held various interim CEO roles. The founding insight centered on the critical need for specialized capital and operational guidance for nascent companies poised to deliver transformative solutions in the evolving healthcare landscape.

Spray Venture Partners targets clinical and technical founders seeking capital and strategic partnership for their groundbreaking innovations. The firm’s vision is to catalyze the creation of companies that not only achieve commercial success but also significantly improve global health outcomes. It stands as a partner committed to advancing medical breakthroughs and enabling the widespread adoption of impactful healthcare technologies.